- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: EGFR sensitive mutation
Total 4940 results
-
Novartis PharmaceuticalsWithdrawn
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung CarcinomaUnited States, Mexico, Bolivia, Peru, Venezuela
-
Aarhus University HospitalOdense University Hospital; Roche Pharma AG; Herning Hospital; Aalborg University...Unknown
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUnknownNon-small Cell Lung Cancer | EGFR Activating Mutation | Leptomeningeal Metastasis
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Non-small Cell Lung CancerChina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompleted
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Tianjin Medical University Cancer Institute and...UnknownNon Small Cell Lung CancerChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungHong Kong, China, Taiwan, Singapore, India
-
ying chengCompletedNon-Small Cell Lung Cancer
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-Small Cell Lung CancerChina
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell LungArgentina, Colombia, Uruguay, Chile
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
Universität Duisburg-EssenTerminatedNon-small-cell Lung Cancer With Somatic EGFR Mutations
-
The University of Hong KongUnknownNSCLC Stage IV | EGFR Activating Mutation | NSCLC Stage IIIBHong Kong
-
Cancer Institute and Hospital, Chinese Academy...UnknownNon-Small Cell Lung Cancer MetastaticChina
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | EGFR Activating Mutation | Stage IV Non-Small Cell Lung Cancer AJCC v7 | ALK Gene Translocation | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | ROS1 Gene TranslocationUnited States
-
Hospital Erasto GaertnerAstraZenecaCompletedLung Neoplasms | KRAS Gene Mutation | EGFR Gene MutationBrazil
-
Betta Pharmaceuticals Co., Ltd.UnknownNon-small Cell Lung Cancer | Brain MetastasesChina
-
Astellas Pharma Global Development, Inc.Terminated
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
AZ-VUBUnknownCancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 MutationBelgium
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Yonsei UniversityUnknownCompletely Resected NSCLC With Common EGFR MutationsKorea, Republic of
-
Clifford Hospital, Guangzhou, ChinaUnknownCarcinoma, Non-Small-Cell LungChina
-
Chong Kun Dang PharmaceuticalCompletedSmall Cell Lung CancerKorea, Republic of
-
Xinqiao Hospital of ChongqingTerminatedNon Small Cell Lung CancerChina
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungSerbia, Thailand, Poland, Romania, Egypt, Philippines, Malaysia
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Betta Pharmaceuticals Co., Ltd.UnknownNon-Small Cell Lung Cancer | Brain Metastases
-
AstraZenecaWithdrawnNon-small Cell Lung Cancer
-
Fujian Cancer HospitalUnknown
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Guangdong Association of Clinical TrialsZhejiang Cancer Hospital; Peking University People's Hospital; Sun Yat-sen University and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
First Affiliated Hospital of Guangxi Medical UniversityUnknownNon-small Cell Lung Cancer
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Sun Yat-sen UniversityUnknown
-
Hebei Medical University Fourth HospitalUnknown
-
Novartis PharmaceuticalsWithdrawnCarcinoma | Non-Small-Cell Lung Cancer
-
Betta Pharmaceuticals Co., Ltd.UnknownNon Small Cell Lung Cancer Stage IIIB | EGFR Gene Mutation | Non Small Cell Lung Cancer Stage IIIAChina
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalCompletedNon-small Cell Lung Cancer (NSCLC)Taiwan